New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 20, 2013
13:41 EDTKOOLHarvest Technologies files amended patent complaint against Thermogenesis
Harvest Technologies announced that it filed an amended patent infringement complaint on February 15 in the US District Court of Delaware against ThermoGenesis (KOOL) and Celling Technologies. The complaint was amended to include Celling Technologies and alleges that the ThermoGenesis' Res-Q 60 BMC system, also sold by Celling Technologies as the ART 21 BMC System, infringes two patents for which Harvest Technology owns the rights. These patents relate to Harvest's proprietary floating shelf technology that has been shown in studies to provide superior cellular concentration. The complaint also requests an injunction against further sales of the product in the U.S. "Harvest Technologies has invested many years and millions of dollars in development of its cellular therapy products," said Gael Tisack, Vice President of Intellectual Property for Terumo Americas Holding. "We will continue to take all steps necessary to ensure that we protect our intellectual property and enforce our patent rights."
News For KOOL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 20, 2014
06:09 EDTKOOLCesca Therapeutics files IDE application for no-option critical limb ischemia
Cesca Therapeutics has submitted an investigational device exemption application to the FDA for a pivotal multicenter study of the company's SurgWerks-CLI and VXP System for treating advanced stages of no-option lower limb critical limb ischemia. The IDE application is the result of two prior positive pilot and feasibility studies conducted in Italy and India, respectively, and collaborative pre-IDE feedback from the U.S. FDA. The primary endpoint is major amputation free survival at 12 months following enrollment.
November 13, 2014
16:02 EDTKOOLCesca Therapeutics reports Q1 EPS (8c), consensus (7c)
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use